Current position: Home >> Scientific Research >> Paper Publications

PPARs在非酒精性脂肪性肝病发病机制中的作用

Release Time:2019-03-10  Hits:

Indexed by: Journal Article

Date of Publication: 2015-06-25

Journal: 生理科学进展

Included Journals: CSCD、ISTIC、PKU

Volume: 46

Issue: 3

Page Number: 220-224

ISSN: 0559-7765

Key Words: 非酒精性脂肪性肝病;过氧化物酶体增殖物激活受体;脂肪酸

Abstract: 非酒精性脂肪性肝病(non-alcoholic fatty liver disease,NAFLD)是西方国家最常见的慢性肝脏疾病,其疾病谱包括肝脂肪变性,脂肪性肝炎,进一步的肝纤维化、肝硬化,甚至肝细胞性肝癌.其发病机制尚未明确,通常解释为“二次打击”学说.然而新的研究发现非甘油三酯在肝脏的沉积,而是脂肪酸(fatty acids,FAs)及其代谢产物等可能对肝脏有毒性作用.过氧化物酶体增殖物激活受体(PPARs)是配体激活的转录因子,是核受体超家族成员之一,具有调节脂质及糖代谢、抗炎和抗纤维化作用,尤其在FAs储存及分解代谢中起到核心作用,与NAFLD的发生发展密切相关,可能作为治疗NAFLD有效靶点.本文将对PPARs在NAFLD发病机制中的作用做一综述.

Prev One:Association between EHBP1 rs721048(A > G) polymorphism and prostate cancer susceptibility: a meta-analysis of 17 studies involving 150,678 subjects

Next One:Association of Monocyte Chemoattractant Protein-1 (MCP-1)-2518A > G Polymorphism with Susceptibility to Coronary Artery Disease: A Meta-Analysis